Gadoxetic acid (cas 135326-11-3)-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category
-
Add time:08/16/2019 Source:sciencedirect.com
PurposeTo evaluate the value of view-sharing multi-hepatic arterial-phase (mHAP) imaging for diagnosis of hypervascular hepatocellular carcinoma (HCC).
We also recommend Trading Suppliers and Manufacturers of Gadoxetic acid (cas 135326-11-3). Pls Click Website Link as below: cas 135326-11-3 suppliers
Prev:T1 mapping on Gadoxetic acid (cas 135326-11-3)-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy
Next:Quantitative analysis of Gadoxetic acid (cas 135326-11-3)-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Liver enhancement in healthy dogs after Gadoxetic acid (cas 135326-11-3) administration during dynamic contrast-enhanced magnetic resonance imaging08/19/2019
- Association between non-hypervascular hypointense nodules on Gadoxetic acid (cas 135326-11-3)-enhanced MRI and liver stiffness or hepatocellular carcinoma08/18/2019
- Quantitative analysis of Gadoxetic acid (cas 135326-11-3)-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma08/17/2019
- T1 mapping on Gadoxetic acid (cas 135326-11-3)-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy08/15/2019
- Biliary tract enhancement in Gadoxetic acid (cas 135326-11-3)-enhanced MRI correlates with liver function biomarkers08/14/2019
- Avoiding Pitfalls in the Interpretation of Gadoxetic acid (cas 135326-11-3)–Enhanced Magnetic Resonance Imaging08/13/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced dynamic magnetic resonance imaging using optimized integrated combination of compressed sensing and parallel imaging technique08/12/2019
- Relationship between transient severe motion of the liver in Gadoxetic acid (cas 135326-11-3) or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes08/11/2019
- Gadoxetic acid (cas 135326-11-3)-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase08/10/2019
-
Health and Chemical more >